Tau protein and beta amyloid in cerebrospinal fluid in patients with multiple sclerosis

被引：0
|
作者：
Talab, R [1 ]
Valis, M [1 ]
Andrys, C [1 ]
Talabova, M [1 ]
Krejsek, J [1 ]
机构：
[1] Fac Hosp, Hradec Kralove, Czech Republic
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2004年 / 154卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
626
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [31] The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases
    Mares, Jan
    Kanovsky, P.
    Herzig, R.
    Stejskal, D.
    Vavrouskova, J.
    Hlustik, P.
    Vranova, H.
    Burval, S.
    Zapletalova, J.
    Pidrman, V.
    Obereigneru, R.
    Suchy, A.
    Vesely, J.
    Podivinsky, J.
    Urbanek, K.
    NEUROLOGICAL SCIENCES, 2009, 30 (01) : 1 - 7
  • [32] The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases
    Jan Mares
    P. Kanovsky
    R. Herzig
    D. Stejskal
    J. Vavrouskova
    P. Hlustik
    H. Vranova
    S. Burval
    J. Zapletalova
    V. Pidrman
    R. Obereigneru
    A. Suchy
    J. Vesely
    J. Podivinsky
    K. Urbanek
    Neurological Sciences, 2009, 30
  • [33] The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid - laboratory markers of neurodegenerative diseases
    Mares, J.
    Herzig, R.
    Stejskal, D.
    Vavrouskova, J.
    Hlustik, P.
    Vranova, H.
    Burval, S.
    Zapletalova, J.
    Pidrman, V.
    Obereingeru, R.
    Suchy, A.
    Vesely, J.
    Podivinsky, J.
    Kanovsky, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S125 - S125
  • [34] The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid laboratory markers of neurodegenerative diseases
    Mares, J.
    Herzig, R.
    Urbanek, K.
    Hlustik, P.
    Vranova, H.
    Sladkova, V.
    Opavsky, R.
    Lubenova, B.
    Kollarova, K.
    Obereigneru, R.
    Sklenarova, J.
    Stejskal, D.
    Vavrouskova, J.
    Zapletalova, J.
    Kanovsky, P.
    JOURNAL OF NEUROLOGY, 2008, 255 : 195 - 195
  • [35] Tau and amyloid β protein in cerebrospinal fluid as biomarkers of Alzheimer's disease
    Kanai, M
    Harigaya, Y
    Kawarabayashi, T
    Ikeda, M
    Okamoto, K
    Shoji, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S380 - S380
  • [36] Simultaneous quantification of Myelin Basic Protein and Tau proteins in cerebrospinal fluid and serum of Multiple Sclerosis patients using nanoimmunosensor
    Derkus, Burak
    Bozkurt, Pinar Acar
    Tulu, Metin
    Emregul, Kaan C.
    Yucesan, Canan
    Emregul, Emel
    BIOSENSORS & BIOELECTRONICS, 2017, 89 : 781 - 788
  • [37] Tau protein in cerebrospinal fluid:: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
    Martínez-Yélamos, A
    Saiz, A
    Bas, J
    Hernandez, JJ
    Graus, F
    Arbizu, T
    NEUROSCIENCE LETTERS, 2004, 363 (01) : 14 - 17
  • [38] Cerebrospinal Fluid Levels of Soluble Amyloid Precursor Protein and β-Amyloid 42 in Patients with Multiple Sclerosis, Neuromyelitis Optica and Clinically Isolated Syndrome
    Mai, W.
    Hu, X.
    Lu, Z.
    Peng, F.
    Wang, Y.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (06) : 2402 - 2413
  • [39] INCIDENCE OF ANTIBODIES IN CEREBROSPINAL FLUID OF PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA
    Villa, Andres M.
    Videla, Cristina
    Garcea, Orlando
    Carballal, Guadalupe
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2009, 67 (3B) : 900 - 901
  • [40] Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot study
    Johansson, Kalle
    Wasling, Pontus
    Novakova, Lenka
    Sjodin, Simon
    Brinkmalm, Ann
    Brinkmalm, Gunnar
    Blennow, Kaj
    Zetterberg, Henrik
    Axelsson, Markus
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
12345